Literature DB >> 23931964

Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.

Malin Huber1, Nermin Hadziosmanovic, Lars Berglund, Jan Holte.   

Abstract

OBJECTIVE: To explore the utility of using the ratio between oocyte yield and total dose of FSH, i.e., the ovarian sensitivity index (OSI), to define ovarian response patterns.
DESIGN: Retrospective cross-sectional study.
SETTING: University-affiliated private center. PATIENT(S): The entire unselected cohort of 7,520 IVF/intracytoplasmic sperm injection treatments (oocyte pick-ups [OPUs]) during an 8-year period (long GnRH agonist-recombinant FSH protocol). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The distribution of the OSI (oocytes recovered × 1,000/total dose of FSH), the cutoff levels for poor and high response, set at ±1 SD, and the relationship between OSI and treatment outcome. RESULT(S): OSI showed a log-normal distribution with cutoff levels for poor and high response at 1.697/IU and 10.07/IU, respectively. A nomogram is presented. Live-birth rates per OPU were 10.5 ± 0.1%, 26.9 ± 0.6%, and 36.0 ± 1.4% for poor, normal, and high response treatments, respectively. The predictive power (C-statistic) for OSI to predict live birth was superior to that of oocyte yield. CONCLUSION(S): The OSI improves the definition of ovarian response patterns because it takes into account the degree of stimulation. The nomogram presents evidence-based cutoff levels for poor, normal, and high response and could be used for unifying study designs involving ovarian response patterns.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Controlled ovarian hyperstimulation; cutoff levels; excessive ovarian response; ovarian sensitivity index; poor ovarian response

Mesh:

Substances:

Year:  2013        PMID: 23931964     DOI: 10.1016/j.fertnstert.2013.06.049

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  23 in total

1.  Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles.

Authors:  Valerie L Baker; Morton B Brown; Barbara Luke; George W Smith; James J Ireland
Journal:  Fertil Steril       Date:  2015-08-18       Impact factor: 7.329

2.  Follicular sensitivity index (FSI): a novel tool to predict clinical pregnancy rate in IVF/ICSI cycles.

Authors:  AbdelGany M A Hassan; Mohamed M M Kotb; Ahmed M A AwadAllah; Nesreen A A Shehata; Amr Wahba
Journal:  J Assist Reprod Genet       Date:  2017-07-03       Impact factor: 3.412

3.  Morphokinetic analysis of cleavage stage embryos and assessment of specific gene expression in cumulus cells independently predict human embryo development to expanded blastocyst: a preliminary study.

Authors:  Stefano Canosa; Loredana Bergandi; Chiara Macrì; Lorena Charrier; Carlotta Paschero; Andrea Carosso; Noemi Di Segni; Francesca Silvagno; Gianluca Gennarelli; Chiara Benedetto; Alberto Revelli
Journal:  J Assist Reprod Genet       Date:  2020-05-20       Impact factor: 3.412

4.  Are ovarian responses and the number of transferable embryos different in females and partners of male balanced translocation carriers?

Authors:  Mingyue Liu; Zhiqin Bu; Yan Liu; Jinhao Liu; Shanjun Dai
Journal:  J Assist Reprod Genet       Date:  2022-08-04       Impact factor: 3.357

5.  Follicular fluid PlGF and IVF/ICSI outcomes among PCOS and normo-ovulatory women using different controlled hyperstimulation protocols: A prospective case-control study.

Authors:  Sally Kadoura; Marwan Alhalabi; Abdul Hakim Nattouf
Journal:  Ann Med Surg (Lond)       Date:  2022-06-25

6.  Are There Ovarian Responsive Indexes That Predict Cumulative Live Birth Rates in Women over 39 Years?

Authors:  Sara Cesarano; Paul Pirtea; Achraf Benammar; Dominique De Ziegler; Marine Poulain; Alberto Revelli; Chiara Benedetto; Alexandre Vallée; Jean Marc Ayoubi
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

7.  Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.

Authors:  H R Nejabati; A Mota; L Farzadi; M Ghojazadeh; A Fattahi; K Hamdi; M Nouri
Journal:  J Endocrinol Invest       Date:  2016-09-23       Impact factor: 4.256

8.  Successful implantation and live birth of a healthy boy after triple biopsy and double vitrification of oocyte-embryo-blastocyst.

Authors:  Ermanno Greco; Anil Biricik; Rocio P Cotarelo; Elisabetta Iammarone; Patrizia Rubino; Jan Tesarik; Francesco Fiorentino; Maria Giulia Minasi
Journal:  Springerplus       Date:  2015-01-14

9.  Menstrual cycle length: a surrogate measure of reproductive health capable of improving the accuracy of biochemical/sonographical ovarian reserve test in estimating the reproductive chances of women referred to ART.

Authors:  Salvatore Gizzo; Alessandra Andrisani; Marco Noventa; Michela Quaranta; Federica Esposito; Decio Armanini; Michele Gangemi; Giovanni B Nardelli; Pietro Litta; Donato D'Antona; Guido Ambrosini
Journal:  Reprod Biol Endocrinol       Date:  2015-04-10       Impact factor: 5.211

10.  Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.

Authors:  Klaus F Bühler; Robert Fischer; Patrice Verpillat; Arthur Allignol; Sandra Guedes; Emmanuelle Boutmy; Wilma Bilger; Emilia Richter; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2021-06-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.